-
EP4320111
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4320111
| EP4320111 - HYDROXYPYRIDINE HSD17B13 INHIBITORS AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 12.01.2024 Database last updated on 16.11.2024 | |
| Former | The international publication has been made Status updated on 14.10.2022 | Most recent event Tooltip | 07.06.2024 | Change: Validation states | published on 10.07.2024 [2024/28] | 07.06.2024 | Change - extension states | published on 10.07.2024 [2024/28] | Applicant(s) | For all designated states Inipharm, Inc. 500 108th Avenue NE, Suite 1100 Bellevue, WA 98004 / US | [2024/07] | Inventor(s) | 01 /
ODINGO, Joshua Bellevue, Washington 98004 / US | 02 /
ANANDAN, Sampath Kumar Bellevue, Washington 98004 / US | 03 /
HSU, Heather Kay Webb Bellevue, Washington 98004 / US | 04 /
FLORIO, Vincent Bellevue, Washington 98004 / US | 05 /
TANTRY, Subramanyam Janardhan Bangalore 560022 / IN | 06 /
DURAISWAMY, Athisayamani Jeyaraj Bangalore 560022 / IN | 07 /
KUPPUSAMY, Bharathi Mohan Bangalore 560022 / IN | [2024/07] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2024/07] | Application number, filing date | 22785244.9 | 04.04.2022 | [2024/07] | WO2022US23350 | Priority number, date | US202163170852P | 05.04.2021 Original published format: US 202163170852 P | [2024/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022216626 | Date: | 13.10.2022 | Language: | EN | [2022/41] | Type: | A1 Application with search report | No.: | EP4320111 | Date: | 14.02.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.10.2022 takes the place of the publication of the European patent application. | [2024/07] | Search report(s) | International search report - published on: | AU | 13.10.2022 | Classification | IPC: | C07D401/12, C07D409/12, A61P1/16, A61P3/00, A61K31/4436, A61K31/517 | [2024/07] | CPC: |
A61P3/00 (EP,AU);
C07D401/12 (EP,AU,US);
A61K31/4436 (US);
A61K31/517 (US);
A61P1/16 (EP,AU);
C07D409/12 (EP,AU,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/07] | Title | German: | HYDROXYPYRIDIN-HSD17B13-INHIBITOREN UND VERWENDUNGEN DAVON | [2024/07] | English: | HYDROXYPYRIDINE HSD17B13 INHIBITORS AND USES THEREOF | [2024/07] | French: | INHIBITEURS D'HSD17B13 DE TYPE HYDROXYPYRIDINE ET LEURS UTILISATIONS | [2024/07] | Entry into regional phase | 04.10.2023 | National basic fee paid | 04.10.2023 | Search fee paid | 04.10.2023 | Designation fee(s) paid | 04.10.2023 | Examination fee paid | Examination procedure | 04.10.2023 | Examination requested [2024/07] | 01.05.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 29.04.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX]WO2022020730 (INIPHARM INC [US]); | [PX]WO2022020714 (INIPHARM INC [US]); | [PX]WO2022029210 (ENYO PHARMA [FR]); | [E]WO2022103960 (INIPHARM INC [US]); |